Clinical trial
Gemcitabine and Oxaliplatin With or Without KN035 for Biliary Tract Cancer: a Randomised, Open-label, Parallel-group, Multicenter Phase III Study
NCT03478488 is registered in ClinicalTrials.gov with 3D Medicines (Sichuan) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine and Oxaliplatin With or Without KN035 for Biliary Tract Cancer: a Randomised, Open-label, Parallel-group, Multicenter Phase III Study
- Lead sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 16, 2018
- Completion date
- September 10, 2024
- Enrollment
- 472 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.